skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Neural stem cell sex dimorphism in aromatase (CYP19) expression: a basis for differential neural fate

Original Research

(1797) Views  (511) Full article downloads

Authors: Jay Waldron, Althea McCourty, Laurent Lecanu

Published Date November 2010 Volume 2010:3 Pages 175 - 182
DOI: http://dx.doi.org/10.2147/SCCAA.S15200

Jay Waldron1, Althea McCourty1, Laurent Lecanu1,2
1The Research Institute of the McGill University Health Centre, Montreal, Canada; 2Department of Medicine, McGill University, Quebec, Canada

Purpose: Neural stem cell (NSC) transplantation and pharmacologic activation of endogenous neurogenesis are two approaches that trigger a great deal of interest as brain repair strategies. However, the success rate of clinical attempts using stem cells to restore neurologic functions altered either after traumatic brain injury or as a consequence of neurodegenerative disease remains rather disappointing. This suggests that factors affecting the fate of grafted NSCs are largely understudied and remain to be characterized. We recently reported that aging differentially affects the neurogenic properties of male and female NSCs. Although the sex steroids androgens and estrogens participate in the regulation of neurogenesis, to our knowledge, research on how gender-based differences affect the capacity of NSCs to differentiate and condition their neural fate is lacking. In the present study, we explored further the role of cell sex as a determining factor of the neural fate followed by differentiating NSCs and its relationship with a potential differential expression of aromatase (CYP19), the testosterone-metabolizing enzyme.
Results: Using NSCs isolated from the subventricular zone of three-month-old male and female Long-Evans rats and maintained as neurospheres, we showed that differentiation triggered by retinoic acid resulted in a neural phenotype that depends on cell sex. Differentiated male NSCs mainly expressed markers of neuronal fate, including ßIII-tubulin, microtubule associated protein 2, growth-associated protein 43, and doublecortin. In contrast, female NSCs essentially expressed the astrocyte marker glial fibrillary acidic protein. Quantification of the expression of aromatase showed a very low level of expression in undifferentiated female NSCs, whereas aromatase expression in male NSCs was 14-fold greater than the female level.
Conclusion: Our results confirm our previous data that the neural phenotype acquired by differentiating NSCs largely depends on cell sex, and that differential expression of aromatase in undifferentiated NSCs might contribute to this sex-based dimorphism. Although still preliminary, our discovery may have clinical application in the development of future brain repair strategies.

Keywords: neuroregenerative medicine, brain repair strategy, sex dimorphism, aromatase, adult stem cells




 

Other articles by Professor Laurent Lecanu



Readers of this article also read:

Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia
Gene transfection in primary stem-like cells of giant cell tumor of bone
Emerging options for the management of age-related macular degeneration with stem cells
Age and sex differences in neural stem cell transplantation: a descriptive study in rats
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Erratum
Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University